Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis

医学 苏伽马德克斯 麻醉 新斯的明 罗库溴铵 神经肌肉阻滞 肺栓塞 肺炎 围手术期 外科 插管 内科学
作者
Sachin Kheterpal,Michelle T. Vaughn,Timur Z. Dubovoy,Nirav J. Shah,Lori D. Bash,Douglas A. Colquhoun,Amy M. Shanks,Michael R. Mathis,Roy G. Soto,Amit Bardia,Karsten Bartels,Patrick J. McCormick,Robert B. Schonberger,Leif Saager
出处
期刊:Anesthesiology [Lippincott Williams & Wilkins]
卷期号:132 (6): 1371-1381 被引量:322
标识
DOI:10.1097/aln.0000000000003256
摘要

BACKGROUND: Five percent of adult patients undergoing noncardiac inpatient surgery experience a major pulmonary complication. The authors hypothesized that the choice of neuromuscular blockade reversal (neostigmine vs. sugammadex) may be associated with a lower incidence of major pulmonary complications. METHODS: Twelve U.S. Multicenter Perioperative Outcomes Group hospitals were included in a multicenter observational matched-cohort study of surgical cases between January 2014 and August 2018. Adult patients undergoing elective inpatient noncardiac surgical procedures with general anesthesia and endotracheal intubation receiving a nondepolarizing neuromuscular blockade agent and reversal were included. Exact matching criteria included institution, sex, age, comorbidities, obesity, surgical procedure type, and neuromuscular blockade agent (rocuronium vs. vecuronium). Other preoperative and intraoperative factors were compared and adjusted in the case of residual imbalance. The composite primary outcome was major postoperative pulmonary complications, defined as pneumonia, respiratory failure, or other pulmonary complications (including pneumonitis; pulmonary congestion; iatrogenic pulmonary embolism, infarction, or pneumothorax). Secondary outcomes focused on the components of pneumonia and respiratory failure. RESULTS: Of 30,026 patients receiving sugammadex, 22,856 were matched to 22,856 patients receiving neostigmine. Out of 45,712 patients studied, 1,892 (4.1%) were diagnosed with the composite primary outcome (3.5% sugammadex vs. 4.8% neostigmine). A total of 796 (1.7%) patients had pneumonia (1.3% vs. 2.2%), and 582 (1.3%) respiratory failure (0.8% vs. 1.7%). In multivariable analysis, sugammadex administration was associated with a 30% reduced risk of pulmonary complications (adjusted odds ratio, 0.70; 95% CI, 0.63 to 0.77), 47% reduced risk of pneumonia (adjusted odds ratio, 0.53; 95% CI, 0.44 to 0.62), and 55% reduced risk of respiratory failure (adjusted odds ratio, 0.45; 95% CI, 0.37 to 0.56), compared to neostigmine. CONCLUSIONS: Among a generalizable cohort of adult patients undergoing inpatient surgery at U.S. hospitals, the use of sugammadex was associated with a clinically and statistically significant lower incidence of major pulmonary complications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
研友_VZG7GZ的应助被开心的语风采纳,获得10
刚刚
刚刚
爱wy发布了新的文献求助10
刚刚
多吃青菜发布了新的文献求助10
刚刚
2816发布了新的文献求助10
1秒前
曙光发布了新的文献求助10
1秒前
高高发布了新的文献求助10
1秒前
xjh的应助被烂漫的书蝶采纳,获得10
1秒前
英勇的修杰完成签到 ,获得积分10
1秒前
欧小猫发布了新的文献求助10
2秒前
2秒前
2秒前
2秒前
2秒前
自觉冰菱发布了新的文献求助10
2秒前
华仔的应助被xinyu采纳,获得10
2秒前
小俊花完成签到,获得积分10
3秒前
tuimao发布了新的文献求助10
3秒前
陈小露完成签到,获得积分20
3秒前
不死鸟发布了新的文献求助10
3秒前
我不爱K头发布了新的文献求助10
3秒前
4秒前
5秒前
汉堡包的应助被tt采纳,获得10
5秒前
5秒前
葛力完成签到,获得积分10
5秒前
典雅秋白发布了新的文献求助10
5秒前
ding的应助被li采纳,获得10
6秒前
6秒前
6秒前
gaoshixun发布了新的文献求助10
7秒前
eisenchen发布了新的文献求助10
7秒前
亚丽发布了新的文献求助10
7秒前
张zh完成签到,获得积分10
7秒前
小芳芳发布了新的文献求助10
7秒前
8秒前
8秒前
coco完成签到,获得积分10
8秒前
ddl发布了新的文献求助30
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153389
求助须知:如何正确求助?哪些是违规求助? 9550014
关于积分的说明 21696271
捐赠科研通 7741851
什么是DOI,文献DOI怎么找? 3425440
关于科研通互助平台的介绍 2550608
邀请新用户注册赠送积分活动 2469123